Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00112346
Status:
COMPLETED
Last Update Posted:
2015-10-28
First Post:
2005-06-01
Brief Title:
Study of GemcitabinePlatinum - Cetuximab as First-Line Treatment for Patients With AdvancedMetastatic Non-Small Cell Lung Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2006-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-06-01
First Submit QC Date:
June 1 2005
Study First Post Date:
2005-06-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-26
Last Update Post Date:
2015-10-28
Last Update Post Date Type:
ESTIMATED